The Latest Trading Price of Eiko Lifesciences Ltd is ₹ 53.65 as of 18 Mar 15:30
. The P/E Ratio of Eiko Lifesciences Ltd changed from 31.1 on March 2025 to 31.1 on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe P/E Ratio of SRF Ltd changed from 27.2 on March 2021 to 69.9 on March 2025 . This represents a CAGR of 20.78% over 5 years The Market Cap of Eiko Lifesciences Ltd changed from ₹ 65.15 crore on March 2025 to ₹ 65.15 crore on March 2025 . This represents a CAGR of 0.00% over 1 yearsThe Market Cap of SRF Ltd changed from ₹ 32030 crore on March 2021 to ₹ 87129 crore on March 2025 . This represents a CAGR of 22.16% over 5 years The revenue of Eiko Lifesciences Ltd for the Dec '25 is ₹ 12.33 crore as compare to the Sep '25 revenue of ₹ 11.97 crore. This represent the growth of 3.01% The revenue of SRF Ltd for the Dec '25 is ₹ 3739 crore as compare to the Sep '25 revenue of ₹ 3665 crore. This represent the growth of 2.02% The ebitda of Eiko Lifesciences Ltd for the Dec '25 is ₹ 2.22 crore as compare to the Sep '25 ebitda of ₹ 2.07 crore. This represent the growth of 7.25% The ebitda of SRF Ltd for the Dec '25 is ₹ 734.06 crore as compare to the Sep '25 ebitda of ₹ 799.86 crore. This represent the decline of -8.23% The net profit of Eiko Lifesciences Ltd changed from ₹ 0.35 crore to ₹ 1.43 crore over 7 quarters. This represents a CAGR of 123.51%
The net profit of SRF Ltd changed from ₹ 252.22 crore to ₹ 432.66 crore over 7 quarters. This represents a CAGR of 36.12%
The Dividend Payout of Eiko Lifesciences Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of SRF Ltd changed from 15.63 % on March 2021 to 16.89 % on March 2025 . This represents a CAGR of 1.56% over 5 years .
About Eiko Lifesciences Ltd
Eiko Lifesciences Limited was originally incorporated on January 07, 1977, under the name Narendra Investments (Delhi) Limited.
Later, the Company changed its name from Narendra Investments (Delhi) Limited to Eiko LifeSciences Limited effective from June 24, 2021.
Earlier, the Company engaged in sale and purchase of shares and securities.
At present, the Company is a leading manufacturer, supplier and exporter of Speciality Chemicals and Pharma Intermediates in India and globally.
The Company commenced new business activity primarily in manufacturing of speciality and fine chemicals in October, 2020 from manufacturing facility located at Badlapur, Maharashtra and has since scaled its operations, grown brand and customer base to become the one of the fastest growing speciality chemicals companies in India.
About SRF Ltd
SRF Limited is a chemical based multi-business entity engaged in the manufacturing of industrial and specialty intermediates.
The Company is a market leader in most of its business segments in India and overseas.
The Company has operations in four countries, India, Thailand, South Africa, and Hungary.
SRF has commercial interests in more than ninety countries and classifies its businesses as Technical Textiles Business (TTB), Chemicals Business (CB), Packaging Films Business (PFB), and Other Businesses.
The principal activities of the Company are manufacturing, purchase and sale of technical textiles, chemicals, packaging films and other polymers.
SRF Limited (SRF) was incorporated on 9th January 1970 under the name of Shriram Fibres Ltd. The change in name of the Company was made in year 1990 from Shriram Fibres Limited to the present name SRF Limited.
FAQs for the comparison of Eiko Lifesciences Ltd and SRF Ltd
Which company has a larger market capitalization, Eiko Lifesciences Ltd or SRF Ltd?
Market cap of Eiko Lifesciences Ltd is 76 Cr while Market cap of SRF Ltd is 76,124 Cr
What are the key factors driving the stock performance of Eiko Lifesciences Ltd and SRF Ltd?
The stock performance of Eiko Lifesciences Ltd and SRF Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Eiko Lifesciences Ltd and SRF Ltd?
As of March 18, 2026, the Eiko Lifesciences Ltd stock price is INR ₹53.65. On the other hand, SRF Ltd stock price is INR ₹2568.1.
How do dividend payouts of Eiko Lifesciences Ltd and SRF Ltd compare?
To compare the dividend payouts of Eiko Lifesciences Ltd and SRF Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.